Loading…

Structure–activity relationships of the peptide deformylase inhibitor BB-3497: modification of the methylene spacer and the P1′ side chain

Structural modifications to the peptide deformylase inhibitor BB-3497 are described. In this paper, we describe the initial SAR around this lead for modifications to the methylene spacer and the P1′ side chain. Enzyme inhibition and antibacterial activity data revealed that the optimum distance betw...

Full description

Saved in:
Bibliographic Details
Published in:Bioorganic & medicinal chemistry letters 2003-08, Vol.13 (16), p.2709-2713
Main Authors: Davies, Stephen J., Ayscough, Andrew P., Beckett, R.Paul, Bragg, Ryan A., Clements, John M., Doel, Sheila, Grew, Christine, Launchbury, Steven B., Perkins, Gemma M., Pratt, Lisa M., Smith, Helen K., Spavold, Zoë M., Thomas, S.Wayne, Todd, Richard S., Whittaker, Mark
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Structural modifications to the peptide deformylase inhibitor BB-3497 are described. In this paper, we describe the initial SAR around this lead for modifications to the methylene spacer and the P1′ side chain. Enzyme inhibition and antibacterial activity data revealed that the optimum distance between the N-formyl hydroxylamine metal binding group and the P1′ side chain is one unsubstituted methylene unit. Additionally, lipophilic P1′ side chains that closely mimic the methionine residue in the substrate provided compounds with the best microbiological profile. Structural modifications to the peptide deformylase inhibitor BB-3497 are described
ISSN:0960-894X
1464-3405
DOI:10.1016/S0960-894X(03)00532-8